Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Human Brain Project: what ethical questions are raised?

Published on: 09/07/2015 Reading time: 1 min
Christine Mitchell, Professeur à l’Université de Harvard
Retour à la recherche

During the Second Neurothics Network meeting, Christine Mitchell, professor at Harvard University and researcher in the "Human Brain Project," explain the mission of the project and some of the ethical questions it raises.

Understanding the human brain is one of the most important challenges of the 21st century. If we meet this challenge, we will better understand what makes us human, develop new treatments and construct informatics infrastructures on a world-wide scale.

The "Human Brain Project" is a European project that will receive 1.2 billion Euros over 10 years. It aims to better understand the human brain and its different pathologies, to simulate it and to map it.

One axe of the project is to centralize and make accessible all data available on the human brain, and thus medical information associated with different pathologies, thanks to information and communication technologies.

The collection of information concerning patients with neurodegenerative diseases and the evolution of the disease as a function of various factors, notably genetic, would allow clinicians to develop precision medicine by extrapolating the data to other patients.

Two categories of questions are raised by the project. The first is not limited to the neurosciences and concerns the collection medical information on patients in a source that is freely accessible to clinicians. This requires assuring the confidentiality of the collected data.

The second category of questions concerns what we learn from the neurosciences. In the near future, for example, it might be possible to predict and modify the behaviour of an individual by electrical stimulation, pharmacological agents or surgery. In the case of an incurable mental disease, this might be desirable but, in other cases, the use of such methods is debatable. Another subject of debate is the authorisation to improve cognitive function in healthy individuals.

"We are in the age of the neurosciences and, in the next decades, we will have much more information on the brain than we ever had. We are full of hopes concerning progress in the neurosciences, particularly for persons suffering from diseases of the brain," Christine Mitchell concluded.

Our news on the subject

Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
Une nouvelle approche pour évaluer les patients en état de conscience altérée
A New Approach to Assessing Patients with Disorders of Consciousness
In intensive care units, some patients who appear unconscious occupy a gray zone in their relationship to the world. To better diagnose them and predict their recovery potential, Dragana Manasova, Jacobo Sitt, and their colleagues have developed an...
01.08.2026 Research, science & health
Ne plus penser à rien : vers une signature cérébrale du blanc mental
Not Thinking About Anything: Toward a Brain Signature of Mind Blanking
What if the flow of our thoughts occasionally just stopped? Esteban Munoz-Musat, Lionel Naccache, Thomas Andrillon, and their colleagues at Paris Brain Institute and Monash University in Melbourne show that the sensation of “thinking about nothing”...
12.26.2025 Research, science & health
Deux nouvelles certifications pour les plateformes de l’Institut du Cerveau
Two new certifications for Paris Brain Institute’s core facilities
Paris Brain Institute’s core facilities were recently awarded two new certifications: ISO 9001 certification for ICM.Quant and ISO 20387 certification for its DNA & Cell Bank.
11.14.2025 Institutional
La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
See all our news